Scott A. Jalowayski




  • JD, summa cum laude, New York Law School, 1998; Articles Editor, New York Law School Law Review
  • MBA, Monterey Institute of International Studies, 1995
  • BA, University of California, Los Angeles, 1991


  • Japan, Gaikokuho Jimu Bengoshi (New York), 2012
  • Hong Kong, Solicitor, 2011
  • New York, 1999

Scott A. Jalowayski


Scott has practiced in Asia since 2000, and is widely recognized as a leading private equity lawyer in the region. In addition to Scott’s experience representing private equity funds, Scott also has deep experience in representing multinationals in cross-border M&A and Joint Venture transactions in a variety of industries, including health care, chemicals, solar energy, natural resources, telecommunications, media, retail, and technology.


  • Global multi-strategy investor in its sale of a 267-room Tokyo hotel.
  • The buyer consortium consisting of TPG Growth and the Chairman of NYSE-listed ShangPharma Corporation in ShangPharma’s 13e-3 going-private transaction valued at approximately US$180 million.
  • A global multi-strategy investor in numerous investments and dispositions over the last decade.
  • TPG Capital and its portfolio company, Nexeo Solutions LLC, in Nexeo's joint venture with the executives of Beijing Plaschem.
  • Bain Capital in the US$489 million sale of Shanghai-based Feixiang Chemicals to Rhodia S.A.
  • D. E. Shaw, as the majority exchangeable bondholders in connection with the US$3.4 billion consolidation of Jiangsu Zhongneng and HKSE-Iisted GCL-Poly Energy. This transaction was awarded Asian Legal Business China 2009 M&A Deal of the Year.
  • Quanta Computer in its joint venture with The 3M Company to manufacture and market touch screen technology solutions.


  • Chambers Asia: Asia’s Leading Lawyers for Business (2009-2015)
  • Chambers Global: The World’s Leading Lawyers for Business (2011, 2013-2015)
  • IFLR 1000: The Guide to the World’s Leading Financial Law Firms (2011)